A detailed history of Jane Street Group, LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 14,225 shares of SERA stock, worth $96,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,225
Previous 11,399 24.79%
Holding current value
$96,730
Previous $67,000 64.18%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.29 - $8.43 $14,949 - $23,823
2,826 Added 24.79%
14,225 $110,000
Q2 2024

Aug 14, 2024

SELL
$5.6 - $11.69 $635,891 - $1.33 Million
-113,552 Reduced 90.88%
11,399 $67,000
Q1 2024

May 15, 2024

BUY
$5.05 - $10.0 $556,681 - $1.1 Million
110,234 Added 749.02%
124,951 $1.14 Million
Q4 2023

Feb 14, 2024

BUY
$1.65 - $6.85 $24,283 - $100,811
14,717 New
14,717 $88,000
Q1 2023

May 15, 2023

BUY
$1.19 - $4.25 $36,303 - $129,654
30,507 New
30,507 $116,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $201M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.